Page last updated: 2024-08-05 11:24:27

furanocoumarin

Any furochromene that consists of a furan ring fused with a coumarin. The fusion may occur in different ways in give several isomers.

ChEBI ID: 24128

Members (27)

MemberDefinitionRole
(R)-(+)-6',7'-dihydroxybergamottin(R)-(+)-6',7'-dihydroxybergamottin
3-(alpha,alpha-dimethylallyl)psoralenChalepensin
4,4'-dimethylangelicin4,4'-Dimethylangelicin
4,4',6-trimethylangelicin4,4',6-Trimethylangelicin
4,5'-dimethylangelicin4,5'-Dimethylangelicin
5-methylangelicin5-Methylangelicin
aflatoxin p1Aflatoxin P1
angelicinangelicin
aviprinoxypeucedanin hydrate
bergamottinbergomottin
chalepinHeliettin
columbianadinAn alpha,beta-unsaturated carboxylic ester obtained by formal condensation of the carboxy group of angelic acid with the hydroxy group of 2-[(8S)-2-oxo-8,9-dihydro-2H-furo[2,3-h][1]benzopyran-8-yl]propan-2-ol.columbianadin
columbianetinThe angular furanocoumarin analogue of the linear furanocoumarin marmesin.columbianetin
columbianetin acetateAn acetate ester obtained by formal acetylation of the tertiary hydroxy group of 2-[(8S)-2-oxo-8,9-dihydro-2H-furo[2,3-h][1]benzopyran-8-yl]propan-2-ol.columbianetin acetate
deltoin(-)-Deltoin
EdultinEdultin
IsobergaptenIsobergapten
nodakeninNodakenin
notopterolNotopterol
OroseloneOroselone
oxypeucadanin, (r)-(+)-isomer(+)-oxypeucedanin
oxypeucadanin, (s)-(-)-isomerA furanocoumarin that is 7H-furo[3,2-g][1]benzopyran-7-one substituted by a [(2S)-3,3-dimethyloxiran-2-yl]methoxy group at position 4.oxypeucedanin
peucedaninA member of the class of furanocoumarins that is furo[3,2-g]chromen-7-one, bearing additional isopropyl and methoxy substituents at positions 2 and 3 respectively.peucedanin
pimpinellinPimpinellin
pyrido(3,4-c)-7-methylpsoralen7-Methylpyrido[3,4-c]psoralen
pyrido(3,4-c)psoralenPyrido[3,4-c]psoralen
sphondinSphondin

Research

Studies (544)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199097 (17.83)18.7374
1990's87 (15.99)18.2507
2000's115 (21.14)29.6817
2010's179 (32.90)24.3611
2020's66 (12.13)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials8 (1.18%)5.53%
Reviews21 (3.09%)6.00%
Case Studies8 (1.18%)4.05%
Observational0 (0.00%)0.25%
Other643 (94.56%)84.16%